BeiGene Ltd (HK:6160) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BeiGene Ltd. is planning to change its English name to BeOne Medicines Ltd., reflecting its commitment to developing innovative cancer treatments. The change is part of a broader strategy to align with its global mission and will not affect shareholders’ rights or trading activities. The new name will be adopted following shareholder approval and registration in Switzerland.
For further insights into HK:6160 stock, check out TipRanks’ Stock Analysis page.